https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-06 / Mol. Ther. 2010 Feb;18(2):275-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-06 / Mol. Ther. 2010 Feb;18(2):275-842009-10-06 00:00:002009-10-06 00:00:00Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-27 / Cell. Immunol. 2009;259(1):13-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-27 / Cell. Immunol. 2009;259(1):13-202009-05-27 00:00:002020-01-08 10:10:17Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Hepatology 2009 Jan;49(1):124-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Hepatology 2009 Jan;49(1):124-322009-01-01 00:00:002020-01-08 10:10:21A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-02 / Cell. Immunol. 2009;254(2):135-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-02 / Cell. Immunol. 2009;254(2):135-412008-10-02 00:00:002019-02-15 09:02:59The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-15 / J Transl Med 2008 Sep;6:51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-15 / J Transl Med 2008 Sep;6:512008-09-15 00:00:002019-02-15 09:11:46In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-01 / Hepatology 2008 Jul;48(1):157-68
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-01 / Hepatology 2008 Jul;48(1):157-682008-07-01 00:00:002008-07-01 00:00:00CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-92008-01-01 00:00:002019-02-15 09:03:01Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-432007-05-24 00:00:002019-02-15 09:03:02Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-37
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-372007-05-01 00:00:002019-02-15 09:11:47AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-21 / Hum. Immunol. 2007 May;68(5):334-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-21 / Hum. Immunol. 2007 May;68(5):334-412007-02-21 00:00:002019-02-15 09:11:48alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro
